New Drug Development Process
New regulatory requirements for first into man studies in France Dominique Tremblay External Expert at the French Medical Agency Agence Française de Sécutrité.
Suzanne Pozsonyi MedicReS World Congress 2013
Wei Liang, Ph.D. FDA / CBER / OCTGT [email protected] Ethical and Social Policy Considerations of Novel Techniques for Prevention of Maternal Transmission.
II French-Chinese Bioethics Workshop Paris 22, 23 February 2007 Jiali LI, MD, Ph.D Cancéropôle Île de France (Cancer Agency of Paris Area)
JB Consulting (MDP) Limited Ethics in the Clinical Development and Medico-Marketing in the Pharmaceutical Industry.
New regulatory requirements for first into man studies in France
Good Clinical Practice in Research
